Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Lung Cancer

  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    November 2020
  1. YI FS, Zhang X, Zhai K, Huang ZY, et al
    TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating TH1/TH17 Cell Response.
    J Immunol. 2020;205:2926-2935.
    PubMed     Abstract available

  2. KOHNO M, Murakami J, Wu L, Chan ML, et al
    Foxp3(+) Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma.
    J Immunol. 2020;205:2519-2531.
    PubMed     Abstract available

    June 2020
  3. ZHANG Z, Huang X, Wang E, Huang Y, et al
    Suppression of Mll1-Complex by Stat3/Cebpbeta-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells.
    J Immunol. 2020;204:3400-3415.
    PubMed     Abstract available

    April 2020
  4. JOHNSON AM, Bullock BL, Neuwelt AJ, Poczobutt JM, et al
    Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.
    J Immunol. 2020;204:2295-2307.
    PubMed     Abstract available

    February 2020
  5. GHOUSE SM, Vadrevu SK, Manne S, Reese B, et al
    Therapeutic Targeting of Vasculature in the Premetastatic and Metastatic Niches Reduces Lung Metastasis.
    J Immunol. 2020;204:990-1000.
    PubMed     Abstract available

    January 2020
  6. NARASIMHAN PB, Eggert T, Zhu YP, Marcovecchio P, et al
    Patrolling Monocytes Control NK Cell Expression of Activating and Stimulatory Receptors to Curtail Lung Metastases.
    J Immunol. 2020;204:192-198.
    PubMed     Abstract available

    December 2019
  7. WANG L, Zeng W, Wang L, Wang Z, et al
    Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation.
    J Immunol. 2019 Dec 23. pii: jimmunol.1900278. doi: 10.4049/jimmunol.1900278.
    PubMed     Abstract available

    April 2019
  8. REGAN DP, Coy JW, Chahal KK, Chow L, et al
    The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.
    J Immunol. 2019 Apr 10. pii: jimmunol.1800619. doi: 10.4049/jimmunol.1800619.
    PubMed     Abstract available

    March 2019
  9. DING C, Sun X, Wu C, Hu X, et al
    Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 Disruption.
    J Immunol. 2019;202:1623-1634.
    PubMed     Abstract available

    February 2019
  10. LEE CC, Ding X, Zhao T, Wu L, et al
    Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells.
    J Immunol. 2019;202:991-1002.
    PubMed     Abstract available

    July 2018
  11. KERDIDANI D, Magkouta S, Chouvardas P, Karavana V, et al
    Cigarette Smoke-Induced Emphysema Exhausts Early Cytotoxic CD8(+) T Cell Responses against Nascent Lung Cancer Cells.
    J Immunol. 2018 Jul 23. pii: jimmunol.1700700. doi: 10.4049/jimmunol.1700700.
    PubMed     Abstract available

    May 2018
  12. WANG Y, Schafer CC, Hough KP, Tousif S, et al
    Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    J Immunol. 2018 May 11. pii: jimmunol.1701069. doi: 10.4049/jimmunol.1701069.
    PubMed     Abstract available

    April 2018
  13. FLORES-VILLANUEVA PO, Ganachari M, Guio H, Mejia JA, et al
    An Isolated TCR alphabeta Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8(+) T Cells To Kill and Secrete IFN-gamma in Response to Lung Adenocarcinoma Cell Lines.
    J Immunol. 2018;200:2965-2977.
    PubMed     Abstract available

    March 2018
  14. NOSAKA T, Baba T, Tanabe Y, Sasaki S, et al
    Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis by Generating Leukotriene B4.
    J Immunol. 2018;200:1839-1852.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.